Becton, Dickinson and Company

Becton, Dickinson and Company produces a range of medical devices primarily focused on blood collection and microbiology. This includes vacuum blood collection tubes like the Microtainer PST and SST, designed for serum and plasma separation, as well as specialized microbiology media such as BBL MYCOPREP and DIFCO products. These are used for culturing and diagnostic testing in clinical settings. The company also manufactures the Phoenix system, a platform for microbiology identification and susceptibility testing.

Becton, Dickinson and Company is headquartered in the United States. While the company operates globally, its primary corporate location is within the US.

Yes, some of Becton, Dickinson and Company’s devices are listed in the EU’s eudamed database. This registry is used to track medical devices that have been authorized for placement on the European market, ensuring transparency and compliance with EU regulations.

Under EU regulations, Becton, Dickinson and Company’s devices fall into multiple risk-based classifications: Class A, Class B, Class C, and Class IIa. The classification determines the regulatory requirements for each device, with higher classes (e.g., Class C) typically requiring more rigorous evaluation due to their associated risks. The specific classification depends on the device’s intended purpose and potential risks to patients.